Triolo A, Bertini J, Mannucci C, Perico A, Pestellini V
Research Division Analytical Department, A. Menarini Industrie Farmaceutiche Riunite S.R.L., Florence, Italy.
J Chromatogr. 1991 Aug 23;568(2):281-9. doi: 10.1016/0378-4347(91)80165-9.
A method for the analysis of platelet-activating factor in platelets employing gas chromatography and selected-ion monitoring mass spectrometry with low-energy electron impact and stable isotope dilution was developed. The procedure involved Bligh and Dyer extraction of the sample followed by thin-layer chromatographic purification. Platelet-activating factor is successively hydrolysed to the corresponding 2-acetyl-1-O-alkylglycerol by digestion with phospholipase C, and the product is allowed to isomerize to the more thermodynamically stable 3-acetyl-1-O-alkylglycerol before column purification and derivatization of the free OH with tert.-butyldimethylchlorosaline-imidazole. This reagent is of common use in platelet-activating factor derivatization, but is made to react with 2-acetyl instead of 3-acetyl isomer. The advantages of using the latter for the final derivatization are discussed and this method is compared with others currently available for gas chromatographic-mass spectrometric analysis of platelet-activating factor.
建立了一种采用气相色谱和具有低能电子轰击及稳定同位素稀释的选择离子监测质谱法分析血小板中血小板活化因子的方法。该方法包括用布莱和戴尔法提取样品,随后进行薄层色谱纯化。血小板活化因子先用磷脂酶C消化依次水解为相应的2-乙酰基-1-O-烷基甘油,产物在进行柱纯化并用叔丁基二甲基氯硅烷-咪唑将游离羟基衍生化之前,先异构化为热力学更稳定的3-乙酰基-1-O-烷基甘油。该试剂在血小板活化因子衍生化中常用,但使其与2-乙酰基异构体而非3-乙酰基异构体反应。讨论了使用后者进行最终衍生化的优点,并将该方法与目前用于血小板活化因子气相色谱-质谱分析的其他方法进行了比较。